Literature DB >> 19817713

Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases.

M Reale1, N H Greig, M A Kamal.   

Abstract

The identification of peripheral biomarkers for neurodegenerative diseases is required to improve the accuracy of clinical diagnosis and monitor both disease progression and response to treatments. The data reviewed in this paper suggest that, in neurodegenerative disease, cytokines are links between peripheral immune system and nervous system dysfunction.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19817713      PMCID： PMC3372240          DOI： 10.2174/138955709789055199

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN： 1389-5575            Impact factor:   3.862


  136 in total

1.  Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients.

Authors:  Marcella Reale; Carla Iarlori; Francesco Gambi; Isabella Lucci; Mirella Salvatore; Domenico Gambi
Journal:  Exp Gerontol       Date:  2005-01-08       Impact factor: 4.032

2.  Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.

Authors:  E Rota; G Bellone; P Rocca; B Bergamasco; G Emanuelli; P Ferrero
Journal:  Neurol Sci       Date:  2006-04       Impact factor: 3.307

3.  Human focal cerebral infarctions induce differential lesional interleukin-16 (IL-16) expression confined to infiltrating granulocytes, CD8+ T-lymphocytes and activated microglia/macrophages.

Authors:  J M Schwab; T D Nguyen; R Meyermann; H J Schluesener
Journal:  J Neuroimmunol       Date:  2001-03-01       Impact factor: 3.478

4.  Increase in circulating levels of monocyte chemoattractant protein-1 with aging.

Authors:  H Inadera; K Egashira; M Takemoto; Y Ouchi; K Matsushima
Journal:  J Interferon Cytokine Res       Date:  1999-10       Impact factor: 2.607

5.  Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.

Authors:  Antón Alvarez; Ramón Cacabelos; Carolina Sanpedro; Manuel García-Fantini; Manuel Aleixandre
Journal:  Neurobiol Aging       Date:  2006-03-29       Impact factor: 4.673

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Impaired production of plasma interleukin-6 in patients with Parkinson's disease.

Authors:  M V Selikhova; N E Kushlinskii; N V Lyubimova; E I Gusev
Journal:  Bull Exp Biol Med       Date:  2002-01       Impact factor: 0.804

Review 9.  TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets.

Authors:  David Tweedie; Kumar Sambamurti; Nigel H Greig
Journal:  Curr Alzheimer Res       Date:  2007-09       Impact factor: 3.498

10.  Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains.

Authors:  M Q Xia; S X Qin; L J Wu; C R Mackay; B T Hyman
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307
View more
  39 in total

1.  Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease.

Authors:  M Reale; M A Kamal; L Velluto; D Gambi; M Di Nicola; N H Greig
Journal:  Curr Alzheimer Res       Date:  2012-05       Impact factor: 3.498

Review 2.  Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

Authors:  Kathryn A Frankola; Nigel H Greig; Weiming Luo; David Tweedie
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-05       Impact factor: 4.388

3.  Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.

Authors:  Giselli Scaini; Meline O S Morais; Leticia S Galant; Francieli Vuolo; Dhébora M Dall'Igna; Matheus A B Pasquali; Vitor M Ramos; Daniel P Gelain; Jose Claudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Francisco G Soriano; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

4.  Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology.

Authors:  Kaori Morimoto; Juri Horio; Haruhisa Satoh; Lucia Sue; Thomas Beach; Seizaburo Arita; Ikuo Tooyama; Yoshihiro Konishi
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity.

Authors:  Weiming Luo; Qian-sheng Yu; Isidro Salcedo; Harold W Holloway; Debomoy K Lahiri; Arnold Brossi; David Tweedie; Nigel H Greig
Journal:  Bioorg Med Chem       Date:  2011-05-23       Impact factor: 3.641

6.  Therapeutic potential of a non-steroidal bifunctional anti-inflammatory and anti-cholinergic agent against skin injury induced by sulfur mustard.

Authors:  Yoke-Chen Chang; James D Wang; Rita A Hahn; Marion K Gordon; Laurie B Joseph; Diane E Heck; Ned D Heindel; Sherri C Young; Patrick J Sinko; Robert P Casillas; Jeffrey D Laskin; Debra L Laskin; Donald R Gerecke
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-13       Impact factor: 4.219

7.  Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis.

Authors:  Michelle A Erickson; William A Banks
Journal:  Brain Behav Immun       Date:  2011-06-17       Impact factor: 7.217

8.  The attenuating effects of plumbagin on pro-inflammatory cytokine expression in LPS-activated BV-2 microglial cells.

Authors:  Samia S Messeha; Najla O Zarmouh; Patricia Mendonca; Malak G Kolta; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2017-09-20       Impact factor: 3.478

9.  Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects.

Authors:  Francisco Arnaldo Viana Lima; Ivan Pinheiro Joventino; Francisca Pinheiro Joventino; Aline Cordeiro de Almeida; Kelly Rose Tavares Neves; Marta Regina do Carmo; Luzia Kalyne Almeida Moreira Leal; Geanne Matos de Andrade; Glauce Socorro de Barros Viana
Journal:  Neurochem Res       Date:  2017-08-31       Impact factor: 3.996

10.  Alpha-synuclein stimulation of astrocytes: Potential role for neuroinflammation and neuroprotection.

Authors:  He-Jin Lee; Changyoun Kim; Seung-Jae Lee
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.